Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS) This pivotal prospective study ...

Tobacco smoking is linked to specific genetic mutations in MDS, affecting chromatin modification and RNA splicing pathways. A dose-response relationship exists, with higher smoking intensity ...

Myelodysplastic syndromes (MDS) and autoimmune conditions appear to have a two-way connection. Living with one may increase your risk of developing the other. Myelodysplastic syndromes (MDS) are a ...

Please provide your email address to receive an email when new articles are posted on . Olutasidenib monotherapy or combination therapy may help certain patients with myelodysplastic syndrome achieve ...

Results of Ontada study to be presented at ASH signals a need to revisit anemia strategies in patients with myelodysplastic syndrome BOSTON & ORLANDO, Fla., December 02, 2025--(BUSINESS WIRE)--Ontada ...

Complications from myelodysplastic syndromes (MDS), like anemia or fatigue, can occur because the bone marrow isn’t making enough healthy or functional blood cells. Myelodysplastic syndromes (MDS) are ...

•Genomic characterization determines diagnosis, classification, and prognostication of the myeloid malignancies myelodysplastic syndrome (MDS) and AML. •Recognizing genetic lesions as invariable ...

Please provide your email address to receive an email when new articles are posted on . Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers.